Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, miRNAs and Genetically Based ResistanceReport as inadecuate




Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, miRNAs and Genetically Based Resistance - Download this document for free, or read online. Document in PDF available to download.

1

Department of Reproductive Biology, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Vasco de Quiroga No. 15, Tlalpan, México 14000, D.F., Mexico

2

Department of Pharmacology, Center for Research and Advanced Studies, Avenida Instituto Politécnico Nacional 2508, México 07360, D.F., Mexico



These authors contributed equally to this work.





*

Author to whom correspondence should be addressed.



Abstract Breast cancer is the most frequent malignancy diagnosed in women. Approximately 70% of breast tumors express the estrogen receptor ER. Tamoxifen and aromatase inhibitors AIs are the most common and effective therapies for patients with ERα-positive breast cancer. Alone or combined with chemotherapy, tamoxifen significantly reduces disease progression and is associated with more favorable impact on survival in patients. Unfortunately, endocrine resistance occurs, either de novo or acquired during the course of the treatment. The mechanisms that contribute to hormonal resistance include loss or modification in the ERα expression, regulation of signal transduction pathways, altered expression of specific microRNAs, balance of co-regulatory proteins, and genetic polymorphisms involved in tamoxifen metabolic activity. Because of the clinical consequences of endocrine resistance, new treatment strategies are arising to make the cells sensitive to tamoxifen. Here, we will review the current knowledge on mechanisms of endocrine resistance in breast cancer cells. In addition, we will discuss novel therapeutic strategies to overcome such resistance. Undoubtedly, circumventing endocrine resistance should help to improve therapy for the benefit of breast cancer patients. View Full-Text

Keywords: endocrine therapy; breast cancer; estrogen receptor; hormonal resistance endocrine therapy; breast cancer; estrogen receptor; hormonal resistance





Author: Rocío García-Becerra 1,†, Nancy Santos 1,2,†, Lorenza Díaz 1 and Javier Camacho 2,*

Source: http://mdpi.com/



DOWNLOAD PDF




Related documents